Biopharmaceutical R&D Working to Fight COVID-19

Scroll to

PhRMA COVID-19 Treatment Progress

America’s biopharmaceutical companies turned a once in a generation challenge into reality by delivering safe and effective COVID-19 vaccines and treatments to patients in record time. COVID-19 vaccines have leaned on new platform technologies and scientific advancements, which have transformed how we fight infectious disease. Innovative treatment approaches have further reduced hospitalizing for severe infection. But our work isn’t done. As variants emerge, the biopharmaceutical industry is working to learn more, be prepared and develop additional solutions to protect us against COVID-19 and future pandemics.

The biopharmaceutical industry has provided financial support and in-kind donations to organizations, patients and first responders, and continues to collaborate with U.S. and global health authorities to combat this global public health emergency.

Our Commitment to Beat Coronavirus

We came together to achieve one shared goal: to beat COVID-19. The groundbreaking COVID-19 vaccines and therapies bring us closer to accomplishing this goal, but we are not done yet. The decades-long investments we have made in new technology, research and treatments have prepared us to act swiftly and allowed us to be in the position to:
Small drop being dropped into test tube
Continue researching and developing potential treatments and vaccines, and conducting clinical trials for additional patient populations.
Doctors walking down a well lit hallway
Dedicate investments in new technologies to stay ahead of emerging variants with safe and effective vaccines.
Doctor taking readings from instruments on a wall
Share the learnings from clinical trials in real time with governments and other companies to advance the development of additional therapies.
Bottles of medicines in a manufacturing setting
Expand our customized manufacturing capabilities via partnerships with fellow biopharmaceutical companies and share available capacity to increase vaccine manufacturing.
Women wearing a mask crossing a crosswalk amongst others in masks
Collaborate with government agencies, hospitals, doctors and others to donate supplies and medicines to help those affected by COVID-19 around the world.
Computer open with stethoscope right along side
Partner with governments and insurers to ensure that treatments and vaccines are available and affordable for all patients.

COVID-19 Vaccinations

Unicef.org Data as of: October 12, 2021, Posted: October 12, 2021 8:00 PM ET

NYTimes Data as of: October 12, 2021. Posted: October 12, 2021 8:00 PM ET

We’ve delivered on the promise of medicine, but our work isn’t done. And while we work hard to beat COVID-19, we’re already thinking about the breakthroughs on the horizon.

Learn more about the COVID-19 work our industry has done.